Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hank

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Surgery (London, England)|February 5, 2024
Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer: systematic review and meta-analysisCarl-Stephan Leonhardt, Thomas Hank, Dietmar Pils, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2021
Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour gradeAnna-Katharina König, Hélène Gros, Ulf Hinz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 24, 2021
Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinomaJoerg Kaiser, Ulf Hinz, Philipp Mayer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 14, 2022
Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinomaCarl-Stephan Leonhardt, Ulf Hinz, Jörg Kaiser, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 20, 2024
High prevalence of pancreatic steatosis in pancreatic cancer patients: A meta-analysis and systematic reviewCătălina Vlăduț, Corinna Steiner, Matthias Löhr, et al.
Annals of Surgery|December 6, 2016
Pancreatic Cancer Surgery: The New R-status CountsOliver Strobel, Thomas Hank, Ulf Hinz, et al.
Annals of Surgery|June 27, 2022
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic CancerThomas Hank, Ulla Klaiber, Ulf Hinz, et al.
British Journal of Cancer|December 4, 2025
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancerChristoph Springfeld, Thilo Hackert, Daniel H Palmer, et al.
Hypoxia (Auckland, N.Z.)|January 30, 2015
Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challengesJonathan Michael Harnoss, Moritz Johannes Strowitzki, Praveen Radhakrishnan, et al.
Annals of Surgical Oncology|March 3, 2026
Optimal Time Between Completion of Preoperative Chemotherapy and Surgery for Locally Advanced Pancreatic CancerMarionna Cathomas, Christoph Kahlert, Thomas Hank, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Surgery (London, England)|February 5, 2024
Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer: systematic review and meta-analysisCarl-Stephan Leonhardt, Thomas Hank, Dietmar Pils, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2021
Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour gradeAnna-Katharina König, Hélène Gros, Ulf Hinz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 24, 2021
Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinomaJoerg Kaiser, Ulf Hinz, Philipp Mayer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 14, 2022
Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinomaCarl-Stephan Leonhardt, Ulf Hinz, Jörg Kaiser, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 20, 2024
High prevalence of pancreatic steatosis in pancreatic cancer patients: A meta-analysis and systematic reviewCătălina Vlăduț, Corinna Steiner, Matthias Löhr, et al.
Annals of Surgery|December 6, 2016
Pancreatic Cancer Surgery: The New R-status CountsOliver Strobel, Thomas Hank, Ulf Hinz, et al.
Annals of Surgery|June 27, 2022
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic CancerThomas Hank, Ulla Klaiber, Ulf Hinz, et al.
British Journal of Cancer|December 4, 2025
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancerChristoph Springfeld, Thilo Hackert, Daniel H Palmer, et al.
Hypoxia (Auckland, N.Z.)|January 30, 2015
Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challengesJonathan Michael Harnoss, Moritz Johannes Strowitzki, Praveen Radhakrishnan, et al.
Annals of Surgical Oncology|March 3, 2026
Optimal Time Between Completion of Preoperative Chemotherapy and Surgery for Locally Advanced Pancreatic CancerMarionna Cathomas, Christoph Kahlert, Thomas Hank, et al.
Pageof 7